Hong Kong stock anomaly | Vimyard Pharmaceutical-B (02561.HK) rose more than 7% in mid-day trading. The company's core product, Longpeptide growth factor, is about to be approved.
According to the Wisdom Financial APP, ViV Healthcare-B (02561.HK) rose more than 7% midday. As of the time of writing, it had increased by 3.64% to HK$31.88.
Latest
